Fundraising Fox
/People
Sign in

Olivier Morand

Investor

Venture Partner at BioMedPartners

Basel, Basel, Switzerland

Find your path to Olivier

138 people in our graph can introduce you to Olivier.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Edward van Wezel to introduce you to Olivier

You →Edward · together at AZAFAROS B.V. (2018–2021) →Olivier

Ask Jamie Chen to introduce you to Olivier

You →Jamie · together at Idorsia Pharmaceuticals Ltd →Olivier

Ask Sam Okafor to introduce you to Olivier

You →Sam · 4 people · together at Actelion Pharmaceuticals Ltd. →Olivier

Sign up to find every way you can get introduced to Olivier

  • Your email: the people you already email who know Olivier
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Olivier
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Biotech leader with expertise in rare metabolic diseases and orphan drugs. Co-founder and former CEO of Azafaros, with senior roles at Actelion and Idorsia. Holds a Doctorate in Biology and Genetics from the University Paris VII.

Experience

  1. BiomedVCVenture Partnercurrent2023 — present
  2. Scenic BiotechSenior Advisor Rare Diseasescurrent2021 — presentAmsterdam, NL
  3. Theralto GmbHFounder, Executive Directorcurrent2018 — presentBasel, Switzwerland
  4. AZAFAROS B.V.Chief Executive Officer2018 — 2021Leiden, The Netherlands
  5. Idorsia Pharmaceuticals LtdSenior Director, Rare Disease Therapeutic area2017 — 2018Allschwil/Basel, Switzerland
  6. Actelion Pharmaceuticals Ltd.Senior Director, Clinical Science Program Head2016 — 2017Allschwil, Switzerland
  7. Actelion Pharmaceuticals Ltd.Senior Director, Clinical Project Team Leader and Scientific Expert2015 — 2016Allschwil, Switzerland
  8. Actelion Pharmaceuticals Ltd.Senior Director, Global Life Cycle Leader2003 — 2015Allschwil, Switzeralnd
  9. RocheScientific Expert, Project Leader, and Peer-Review Committee member1989 — 2003Basel, Basel, Switzerland
  10. Merck & Co., Inc.Research Scientist1988 — 1989Rahway, NJ, USA
  11. University of Wisconsin–Madison Department of BiochemistryResearch Associate1985 — 1988Madison, WI, USA
  12. INSERM, Hôpital de la Pitié-Salpêtrière, Department of NeurochemistryChargé de Recherche1982 — 1985Greater Paris Metropolitan Region
  13. Mount Sinai School of Medicine, Department of Human GeneticsPost-Doctoral Fellow:1981New York, NY, USA
  14. Hadassah Medical School, Hebrew UniversityPost-Doctoral Fellow:1980Jerusalem, Israel

Skills & more

Clinical Trials9Cardiology2Pharmaceutical Sales3Clinical Development9Project Management5GCP5Oncology3Strategic Planning3Pharmaceutical Industry11

From Olivier's professional profile.

Colleagues at BioMedPartners

Aristotelis Nastos
Managing Partner at BioMedPartners
Claudia Ulbrich
Venture Partner at BioMedPartners
David Urech
Venture Partner at BioMedPartners
Dr. Aristotelis Nastos
Managing Partner at BioMedPartners
Dr. Claudia Ulbrich
Venture Partner at BioMedPartners
Dr. David Urech
Venture Partner at BioMedPartners
Dr. Marianna Feretzaki
Senior Associate at BioMedPartners
Dr. Markus Hosang
Managing Partner at BioMedPartners

Frequently asked questions

Who is Olivier Morand?
Biotech leader with expertise in rare metabolic diseases and orphan drugs. Co-founder and former CEO of Azafaros, with senior roles at Actelion and Idorsia. Holds a Doctorate in Biology and Genetics from the University Paris VII.
Where does Olivier Morand work?
Olivier Morand is Venture Partner at BioMedPartners.
Where did Olivier Morand go to school?
Olivier Morand studied at IMD (Program for Executive Development); University Paris VII (Doctorat d'Etat ès Sciences, Biology and Genetics); University Paris VI, France (Doctorat de 3ème Cycle, Nutrition).

Same school

Shared employers

Also worked at Idorsia Pharmaceuticals Ltd1

Katharina VenturiChief Operating Officer at Page Therapeutics